Peptor Overview

  • Founded
  • 1993
  • Status
  • Acquired/​Merged
  • Employees
  • 53
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $69.7M
Latest Deal Amount

Peptor General Information


Developer of products to treat autoimmune diseases. The company develops small cyclical analogues of peptide loop drugs to treat cancer, bacterial and fungal infections, autoimmune diseases, multiple sclerosis and other disorders.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Kiryat Weizmann
  • Rehovot 78326
  • Israel
+972 00-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Peptor Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 17-May-2004 $69.7M 000.00 000.00 Completed Generating Revenue
7. Later Stage VC 01-Nov-1999 0000 000.00 0000 Completed Generating Revenue
6. Later Stage VC 29-Sep-1998 0000 000.00 Completed Startup
5. IPO 25-Jun-1997 Cancelled Startup
4. Early Stage VC 01-May-1996 000.00 000.00 Completed Startup
3. Early Stage VC 01-Nov-1995 000 0000 Completed Startup
2. Early Stage VC 01-Dec-1993 $10M $11M Completed Startup
1. Seed Round 01-May-1993 $1M $1M Completed Startup
To view Peptor’s complete valuation and funding history, request access »

Peptor Executive Team (4)

Name Title Board Seat Contact Info
Dana Elias Senior Vice President & Chief Technology Officer
You’re viewing 1 of 4 executive team members. Get the full list »

Peptor Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Peptor Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
AlpInvest Partners PE/Buyout Minority 000 0000 000000 0
Ampal Venture Capital Minority 000 0000 000000 0
Citibank Corporation Minority 000 0000 000000 0
Clal Biotechnology Industries Venture Capital Minority 000 0000 000000 0
David Blech & Co Other Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »